Reversal of ApoE4-driven brain pathology by vascular endothelial growth factor treatment

S Salomon-Zimri, MJ Glat, Y Barhum… - Journal of …, 2016 - content.iospress.com
Abstract Apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for Alzheimer's
disease (AD), is associated with increased neurodegeneration and vascular impairments …

Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.

S Salomon-Zimri, MJ Glat, Y Barhum, I Luz… - Journal of Alzheimer's …, 2016 - europepmc.org
Apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for Alzheimer's disease
(AD), is associated with increased neurodegeneration and vascular impairments. Vascular …

Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment

S Salomon-Zimri, MJ Glat, Y Barhum… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for Alzheimer's disease
(AD), is associated with increased neurodegeneration and vascular impairments. Vascular …

[PDF][PDF] Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment

S Salomon-Zimria, MJ Glatb, Y Barhumb… - Journal of Alzheimer's …, 2016 - researchgate.net
Apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for Alzheimer's disease
(AD), is associated with increased neurodegeneration and vascular impairments. Vascular …